US 6,789,117 C11

URI: https://gptkb.org/entity/US_6%2C789%2C117_C11
GPTKB entity
Properties (60)
Predicate Object
gptkbp:instanceOf patent
gptkbp:abstract A method for treating disease.
gptkbp:applicationNumber 10/123,456
gptkbp:applicationType non-provisional.
gptkbp:assignee gptkb:ABC_Corporation
ABC_Corporation.
gptkbp:citedBy gptkb:US_7,123,456_B2
gptkbp:claims 20
gptkbp:class A61K
gptkbp:country United_States.
gptkbp:examiner Jane_Smith
gptkbp:expirationDate March 1, 2022
gptkbp:fieldOfInvention medicinal chemistry.
gptkbp:fieldOfUse pharmaceuticals
gptkbp:filingCountry USA.
gptkbp:filingDate April 1, 2002
gptkbp:firstClaim A compound of formula X.
https://www.w3.org/2000/01/rdf-schema#label US 6,789,117 C11
gptkbp:internationalClassification C07D 401/12
gptkbp:inventor gptkb:John_Doe
John_Doe.
gptkbp:inventorCountry USA.
gptkbp:issueDate September 7, 2004
gptkbp:issuedOn September 7, 2004
gptkbp:language English.
gptkbp:legalStatus granted
gptkbp:maintenanceFee paid
gptkbp:nonPatentCitation Journal_of_Medicinal_Chemistry.
gptkbp:patentAbstract English.
A method for treating disease using a specific compound.
gptkbp:patentCitation US_5,123,456_A.
US_7,123,456_B2.
gptkbp:patentClaim 20 claims.
gptkbp:patentClassification A61K 31/00.
A61K.
C07D_401/12.
gptkbp:patentExpiration March 1, 2022.
gptkbp:patentFamily US_6,789,117_C11_family.
gptkbp:patentFamilyMembers US_6,789,116_C11.
gptkbp:patentFilingDate granted patent.
April 1, 2002.
September 7, 2004.
gptkbp:patentInventor Jane_Smith.
United_States.
gptkbp:patentLink https://patents.google.com/patent/US6789117.
gptkbp:patentMaintenanceFee paid.
gptkbp:patentNumber 6,789,117.
gptkbp:patentOffice USPTO.
gptkbp:patentStatus active.
granted.
gptkbp:patentType utility
Utility patent.
US_6,789,116_C11.
US_6,789,118_C11.
gptkbp:priorityDate March 1, 2002
gptkbp:publications granted patent.
gptkbp:relatedPatent US_6,789,118_C11
gptkbp:relatedTo gptkb:US_6,789,116_C11
gptkbp:status active
gptkbp:subclass A61K 31/00